Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) and are scheduled for a planned procedure to restore normal heart rhythm using an electrical shock
- People whose overall physical health is rated as class I, II, or III on a standard scale used by anesthesiologists to assess fitness for procedures (confirm with trial site)
- People whose heart pumps at least 30% of its blood volume per beat, as confirmed by an ultrasound of the heart
- People who have adequate blood-thinning (anticoagulation) coverage, which may be confirmed in one of three ways: a blood clotting level (INR) of 2.0 or above, at least three weeks of consistent blood-thinning medication at the right dose, or a confirmed absence of blood clots in the upper heart chambers shown by a specialised heart ultrasound
- People who are willing and able to give written consent to participate
Who may not be able to join:
- People with a known allergy or medical reason to avoid propofol or fentanyl (the sedation medications used in this trial), or their ingredients, including soy or egg
- People with unstable blood pressure — specifically, a systolic (top number) blood pressure below 90 mmHg, or symptoms caused by low blood pressure
- People with severely worsened heart failure that significantly limits activity even at rest (known as NYHA class IV)
- People with severe obstructive sleep apnea who require a CPAP or BiPAP breathing machine
- People whose airway is assessed as likely to be difficult to manage during sedation, based on a standard clinical scoring system (confirm with trial site)
- People whose blood oxygen level at rest is below 94%, or who have active chronic obstructive pulmonary disease (a long-term lung condition)
- People with severe liver problems (based on specific blood test results) or severely reduced kidney function (based on a kidney filtration rate below a certain threshold)
- People with an active mental health condition or significant memory or thinking difficulties that would prevent them from completing study questionnaires
- People who are pregnant or breastfeeding
- People who have consumed alcohol or any other substances within the 24 hours before the procedure
- People who have already taken part in this trial previously
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kerem Erkalp, Professor Dr, Istanbul University - Cerrahpasa
Phone: +905326343959
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to Recovery (Modified Aldrete Score ≥9)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.